Skip to:
Support us
Find people, groups, projects, media, etc.
Commonly searched
-

Publications

Browse publications attributed to Doherty Institute researchers

Overview

Research publications at the Doherty Institute

Our commitment to advancing knowledge in infectious diseases and immunology is reflected in a growing body of peer-reviewed research. This page provides access to published studies from our world-class scientists and collaborators, showcasing breakthroughs that inform policy, improve clinical practice, and drive innovation to improve health outcomes. Browse our collection to stay informed on the latest scientific insights shaping the future.

Filters
Year
Staff Members

Showing publications from Dr Jenny Anderson (37)

HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.

2025 · journal-article
BackgroundEradication of HIV cannot be achieved with combination antiretroviral therapy (cART) because of the persistence of long-lived latently infected resting…

Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency.

2025 · journal-article
BackgroundOne strategy being pursued to clear latently infected cells that persist in people living with HIV (PLWH) on antiretroviral therapy…

CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4+ T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and Maintained.

2025 · journal-article
HIV can persist in people living with HIV (PLWH) on antiretroviral therapy (ART) in multiple CD4+ T cell subsets, including…

Combination Immune Checkpoint Blockade to Reverse HIV Latency.

2025 · journal-article
In people living with HIV on antiretroviral therapy, HIV latency is the major barrier to a cure. HIV persists preferentially…

Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV

2023 · journal-article

Hepatitis B Surface Expression is Up-Regulated by HIV Tat Protein in Co-Infected Hepatocytes with Significant Transcriptomic Changes Favouring Adverse Liver Outcomes

2023 · other

Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice

2023 · journal-article

Human Immunodeficiency Virus (HIV)-Infected CCR6+ Rectal CD4+ T Cells and HIV Persistence On Antiretroviral Therapy.

2020 · journal-article
BackgroundIdentifying where human immunodeficiency virus (HIV) persists in people living with HIV and receiving antiretroviral therapy is critical to develop…

Limitations of dual‐fluorescent HIV reporter viruses in a model of pre‐activation latency

2019 · journal-article

HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.

2019 · journal-article
OBJECTIVE:To determine whether latency can be established and reversed in both proliferating and nonproliferating CD4+ T cells in the same…

HIV latency reversing agents act through Tat post translational modifications.

2018 · journal-article
BackgroundDifferent classes of latency reversing agents (LRAs) are being evaluated to measure their effects in reactivating HIV replication from latently…

Getting the “Kill” into “Shock and Kill”: Strategies to Eliminate Latent HIV.

2018 · journal-article
Despite the success of antiretroviral therapy (ART), there is currently no HIV cure and treatment is life long. HIV persists…

Cancer therapies in HIV cure research.

2017 · journal-article
Purpose of reviewThis article provides an overview of anticancer therapies in various stages of clinical development as potential interventions to…

Human immunodeficiency virus persistence and T-cell activation in blood, rectal, and lymph node tissue in human immunodeficiency virus-infected individuals receiving suppressive antiretroviral therapy

2017 · journal-article

Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.

2016 · journal-article
Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed.…

Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.

2016 · journal-article
BackgroundHIV latent infection can be established in vitro by treating resting CD4 T cells with chemokines that bind to chemokine…

The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.

2015 · journal-article
BackgroundCombination antiretroviral therapy (cART) is able to control HIV-1 viral replication, however long-lived latent infection in resting memory CD4(+) T-cells…

Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.

2015 · journal-article
Receive the latest news and updates straight to your inbox
Site by Sod